ClinicalTrials.Veeva

Menu

Blended Unified Protocol for Chinese Adolescents With Non-Suicidal Self-Injury: A Randomized Controlled Trial

J

Jian-Jun Ou

Status

Not yet enrolling

Conditions

Non-suicidal Self-injury (NSSI)

Treatments

Behavioral: a blended version of the Unified Protocol for Adolescents (UP-A)
Drug: Standard psychiatric treatment

Study type

Interventional

Funder types

Other

Identifiers

NCT07110181
E2024193

Details and patient eligibility

About

This study is an open-label, randomized controlled trial evaluating the efficacy of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Adolescents (UP-A) in reducing non-suicidal self-injury (NSSI) among Chinese adolescents. This program is an annualized cognitive-behavioral therapy designed for adolescents aged 12-17 years who engage in non-suicidal self-injury behavior. Its primary goal is to reduce the intensity and frequency of distressing emotional experiences by teaching adolescents how to confront and respond to these emotions in more adaptive ways. In turn, this helps reduce self-injury impulses and behaviors. The UP-A is adapted to the Chinese cultural context and delivered as a blended treatment, combining face-to-face and online sessions.

Enrollment

60 estimated patients

Sex

All

Ages

12 to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Aged between 12 and 17 years;
  2. Engaged in non-suicidal self-injury (NSSI) at least 5 times in the past 12 months, with at least 1 episode in the past month;
  3. Minimum education level of primary school or above;
  4. Participant and guardian fully understand the research content and agree to participate, with signed informed consent provided.

Exclusion criteria

  1. Suicide attempts in the past month or a score of ≥17 on the MINI National Neuropsychiatric Interview for Children (MINI KID 5.0), indicating a high risk of suicide;
  2. Diagnosis of a psychotic disorder, autism spectrum disorder, or other serious neurodevelopmental disorders according to the DSM-5;
  3. Presence of severe physical illness or other medical conditions that may affect the completion of treatment and evaluation;
  4. Currently receiving other professional psychotherapy or participating in another NSSI intervention study;
  5. Received 5 or more sessions of cognitive behavioral therapy (CBT) in the past 5 years;
  6. Having received electroconvulsive therapy (ECT) within the past 6 months.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

UP-A + Treatment as Usual
Experimental group
Description:
Participants receive standard psychiatric care (e.g., pharmacotherapy) plus a blended version of the Unified Protocol for Adolescents (UP-A), which includes both face-to-face and online sessions over 8 weeks.
Treatment:
Drug: Standard psychiatric treatment
Behavioral: a blended version of the Unified Protocol for Adolescents (UP-A)
Treatment as Usual
Active Comparator group
Description:
Participants in the control group will receive standard psychiatric care as provided by their treating clinicians, including pharmacotherapy as appropriate. No additional psychological intervention will be provided during the study period.
Treatment:
Drug: Standard psychiatric treatment

Trial contacts and locations

1

Loading...

Central trial contact

Jianjun Ou, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems